534 results on '"Concin, Nicole"'
Search Results
152. Abstract 1417: Expression of BARD1δ induces genetic instability and is associated with cervical carcinogenesis
153. Clinical characterization of long term survivors (LTS) in ovarian cancer (OC): Results of a propensity score matched (PSM) analysis of the international prospective tumor bank for ovarian cancer (TOC Network).
154. Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice
155. The Impact of the Duration of Adjuvant Chemotherapy on Survival in Patients with Epithelial Ovarian Cancer – A Retrospective Study
156. L1CAM in the Early Enteric and Urogenital System
157. Strong antitumor synergy between DNA crosslinking and HSP90 inhibition causes massive premitotic DNA fragmentation in ovarian cancer cells
158. Clonal Hematopoiesis in Whole-Blood and Cell-Free DNA of Ovarian Cancer Patients Undergoing PARP-Inhibitor Treatment: An Exploratory Analysis of the ENGOT-ov48/Eudario Trial
159. WEEKLY PACLITAXEL-CARBOPLATINUM IS EFFECTIVE IN PLATINUM-RESISTANT OVARIAN CANCER PATIENTS AFTER PREVIOUS WEEKLY PACLITAXEL
160. Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer
161. γ-Glutamyltransferase and Breast Cancer Risk Beyond Alcohol Consumption and Other Life Style Factors – A Pooled Cohort Analysis
162. Kontamination des m��tterliche Fettgewebes und der Muttermilch mit Mineral��l-Kohlenwasserstoffen : Hinweis auf Kosmetika als wichtige Quellen
163. The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients—results from the OVCAD study
164. Part I of GANNET53: A multicenter phase I/II trial of the Hsp90 inhibitor ganetespib (G) combined with weekly paclitaxel (P) in women with high-grade serous, high-grade endometrioid, or undifferentiated, platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancer.
165. Prognostic Relevance of Pretherapeutic Gamma-Glutamyltransferase in Patients with Primary Metastatic Breast Cancer
166. Mineral oil in human tissues, Part II: Characterization of the accumulated hydrocarbons by comprehensive two-dimensional gas chromatography
167. The clinical revalence of p53 isoforms in ovarian cancer
168. The effect of p53 isoforms/splice variants on p73 activity
169. HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer – a study of the OVCAD Consortium
170. 61 - The Application of a Hybridisation-Based Next-Generation Sequencing (NGS) Enrichment Panel for the Analysis of Key Genes Involved in Ovarian and Breast Tumours Using DNA From FFPE Samples
171. L1CAM in the Early Enteric and Urogenital System.
172. p53 in Human Cancer — Somatic and Inherited Mutations and Mutation-independent Mechanisms
173. HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer – a study of the OVCAD Consortium
174. Erratum to “Quantitative levonorgestrel plasma level measurements in patients with regular and prolonged use of the levonorgestrel-releasing intrauterine system” [Contraception 86 (2012) 345–349]
175. Treatment reality in elderly patients with advanced ovarian cancer: a prospective analysis of the OVCAD consortium
176. The role of gamma-glutamyltransferase in malignant transformation and prognosis of ovarian cancer.
177. A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer - a study of the OVCAD consortium
178. The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients-results from the OVCAD study.
179. Quantitative levonorgestrel plasma level measurements in patients with regular and prolonged use of the levonorgestrel-releasing intrauterine system
180. Prognostic Value of Lymph Node Ratio and Clinicopathologic Parameters in Patients Diagnosed With Stage IIIC Endometrial Cancer
181. Nomogram prediction for overall survival of patients diagnosed with cervical cancer.
182. Interval versus primary tumor debulking surgery in advanced ovarian cancer: Analysis of the European OVCAD data.
183. The N-Terminally Truncated p53 Isoform Δ40p53 Influences Prognosis in Mucinous Ovarian Cancer
184. Prognostic Value of Residual Tumor Size in Patients With Epithelial Ovarian Cancer FIGO Stages IIA–IV: Analysis of the OVCAD Data
185. Strong antitumor synergy between DNA crosslinking and HSP90 inhibition causes massive premitotic DNA fragmentation in ovarian cancer cells
186. MDM2 SNP309 modifies the prognostic significance of the p53 mutational status in patients with ovarian cancer
187. Evidence for Cosmetics as a Source of Mineral Oil Contamination in Women
188. Clinical Relevance of TAp73 and ΔNp73 Protein Expression in Ovarian Cancer
189. Does duration of hysteroscopy increase the risk of disease recurrence in patients with endometrial cancer? A multi-centre trial
190. Gene expression of PMP22 is an independent prognostic factor for disease-free and overall survival in breast cancer patients
191. E2F3a Is Critically Involved in Epidermal Growth Factor Receptor–Directed Proliferation in Ovarian Cancer
192. The presence of postmenopausal bleeding as prognostic parameter in patients with endometrial cancer: a retrospective multi-center study
193. Plasma Fibrinogen Levels and Prognosis in Patients with Ovarian Cancer: A Multicenter Study
194. Optimizing the dose of upifitamab rilsodotin (UpRi; XMT-1536), a NaPi2b-directed dolaflexin antibody drug conjugate (ADC): A posthoc analysis of a phase 1b expansion study in ovarian cancer (319).
195. Response to: Correspondence on "ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors" by Thomassin-Nagarra et al.
196. Influence of the Time Interval Between Hysteroscopy, Dilation and Curettage, and Hysterectomy on Survival in Patients With Endometrial Cancer
197. Serum C-Reactive Protein as Independent Prognostic Variable in Patients with Ovarian Cancer
198. Vascular endothelial growth factor gene polymorphisms in ovarian cancer
199. Vascular Endothelial Growth Factor Gene Polymorphisms Are Associated with Prognosis in Ovarian Cancer
200. Clinical Relevance of E2F Family Members in Ovarian Cancer—An Evaluation in a Training Set of 77 Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.